The effect of nanomicelle curcumin in children with Crohn's disease

Phase 3

Recruiting

• Conditions: Children's Crohn's disease.; Crohn's disease [regional enteritis]

• Registration Number: IRCT20231029059889N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Children 8 to 18 years old with Crohn's disease
Mild to moderate disease severity based on Crohn's Disease Activity Index (CDAI)
Interested in participating in the project and willing to follow the study protocol
Informed consent has been obtained from the patients

Exclusion Criteria

Using anticoagulants such as warfarin or antiplatelet
Pregnancy and breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum albumin. Timepoint: At the beginning of the study (before the start of the intervention) and12 weeks after the start of the supplement consumption. Method of measurement: Biochemical analysis of blood sample.;Body mass index. Timepoint: At the beginning of the study (before the start of the intervention) and12 weeks after the start of the supplement. Method of measurement: Formula (weight/height squared).;Body weight. Timepoint: At the beginning of the study (before the start of the intervention) and 4, 8 and 12 weeks after the start of the supplement consumption. Method of measurement: Scales.;Height. Timepoint: At the beginning of the study (before the start of the intervention) and 4, 8 and 12 weeks after the start of the supplement consumption. Method of measurement: tape measure.